PhD (Institute for Genetics, University of Cologne, Germany)
Martin Pal is an expert in genome editing and CRISPR technology, and has extensive research experience across multiple disease contexts, including metabolic disorders and cancer.
He obtained his PhD in Genetics in 2012 from one of the leading institutes in gene targeting technologies, and following a move to Australia in 2013, he has since performed postdoctoral research at four of Australia’s preeminent Medical Research Institutes:
During his time at WEHI, Martin was part of the Melbourne Advanced Genome Editing Centre (MAGEC), applying CRISPR-Cas9 technology for disease modelling and research into cell death and blood cancers.
Most of his original research work includes specifically generated disease models targeting diverse pathological contexts, which has resulted in multiple high-impact publications.
Martin joined the School of Dentistry and Medical Sciences in August 2021 and is currently setting up his research activities at the School.
Martin Pal is an enthusiastic science educator striving to create an environment where students can flourish. In his teaching he utilizes his extensive background in science, genome editing and disease research to guide students through basic concepts in science.
He is passionate about breaking down complex scientific and molecular technologies into easily understandable information and has developed a growing portfolio of online educational resources showcasing advanced technologies, such as genome editing with CRISPR.
Martin is driven to foster a skillset within undergraduate and HDR students that helps them to succeed in their studies and future career stages.
He is currently teaching within the Medical Sciences subjects, including Molecular Pathology, Molecular and Cellular Biology, and Microbiology.
Martin’s overall research theme is to investigate origins of disease with the ultimate aim of finding novel therapeutic avenues. His research utilizes innovative and advanced genome editing techniques, including CRISPR-Cas technology.
Current Research Interests: